Shopping Cart
- Remove All
- Your shopping cart is currently empty
R-10015 is a highly potent and selective LIMK inhibitor that blocks LIMK by binding to the ATP-binding pocket. It inhibits human LIMK1 with an IC50 value of 38 nM. It also exerts broad-spectrum antiviral effects and may be used in HIV infection research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $69 | In Stock | |
5 mg | $173 | In Stock | |
10 mg | $270 | In Stock | |
25 mg | $445 | In Stock | |
50 mg | $592 | In Stock | |
100 mg | $833 | In Stock | |
200 mg | $1,130 | In Stock | |
1 mL x 10 mM (in DMSO) | $191 | In Stock |
Description | R-10015 is a highly potent and selective LIMK inhibitor that blocks LIMK by binding to the ATP-binding pocket. It inhibits human LIMK1 with an IC50 value of 38 nM. It also exerts broad-spectrum antiviral effects and may be used in HIV infection research. |
Targets&IC50 | LIMK1 (human):38 nM |
In vitro | R10015 as a lead compound that blocks LIMK activity by binding to the ATP-binding pocket.?R10015 specifically blocks viral DNA synthesis, nuclear migration, and virion release.?In addition, R10015 inhibits multiple viruses, including Zaire ebolavirus (EBOV), Rift Valley fever virus (RVFV), Venezuelan equine encephalitis virus (VEEV), and herpes simplex virus 1 (HSV-1), suggesting that LIMK inhibitors could be developed as a new class of broad-spectrum antiviral drugs. |
Molecular Weight | 410.86 |
Formula | C20H19ClN6O2 |
Cas No. | 2097938-51-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 62.5 mg/mL (152.12 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.